The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: Multicenter observational study to evaluate the relationship between gut bacterial flora and their therapeutic or adverse effects in advanced non-small cell lung cancer patients treated with nivolumab.
 
Takashi Yokoi
Speakers' Bureau - AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Novartis; Ono Pharmaceutical
Research Funding - Ono Pharmaceutical
 
Ryo Itotani
No Relationships to Disclose
 
Maiko Niki
No Relationships to Disclose
 
Hiroshige Yoshioka
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Lilly; MSD K.K; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
 
Katsuya Hirano
No Relationships to Disclose
 
Suguru Yamamoto
No Relationships to Disclose
 
Hideki Ishikawa
No Relationships to Disclose
 
Takashi Kijima
No Relationships to Disclose
 
Masataka Hirabayashi
No Relationships to Disclose
 
Motonari Fukui
No Relationships to Disclose